Split Biosciences

📍 Seattle, United States🗓 Founded 2018👥 7 employees💰 Last funded Sep 2018
Biotechnology🌐 splitbio.com
Website LinkedIn
Split Biosciences is a Seattle-based startup providing researchers access to the most scalable single cell sequencing platform available. With technology founded on the principles of SPLiT-seq, published in Science in 2018, Split Bio's mission is to accelerate progress in scientific research as well as human health. Single-cell sequencing has already enabled groundbreaking discoveries that have led to new understandings in cancer treatment, tissue repair, stem cell therapy, the immune system and much more. At Split Bio we provide researchers with the ability to perform single cell sequencing with unprecedented scale and ease.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Split Biosciences?
Split Biosciences has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Split Biosciences last raise funding?
The most recent investment in Split Biosciences recorded on gritt.io was in September 2018.
When was Split Biosciences founded?
Split Biosciences was founded in 2018.
What industry is Split Biosciences in?
Split Biosciences operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Split Biosciences based?
Split Biosciences is headquartered in Seattle, United States.